IMIDomics
OverviewSuggest Edit
IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. It utilizes a platform that integrates access to a dynamic IMID patient biobank, curated clinical data, proprietary multiomics molecular data, and clinical expertise. IMIDomics analytics platform extracts insights into disease biology and patient conditions through a proprietary interactive portal.
| Type | Private | |
| Founded | 2015 | |
| Website | imidomics.com |
Latest Updates
| Employees (est.) (May 2020) | 3 | |
| Cybersecurity rating | B | More |
IMIDomics Financials and Metrics
Summary Metrics
Founding Date | 2015 |
IMIDomics Cybersecurity Score
IMIDomics Online and Social Media Presence
5 Twitter followers
IMIDomics has 5 Twitter Followers. The number of followers has increased 42.9% quarter over quarter
IMIDomics's Trends
Twitter Engagement Stats for @IMIDomics
7
Tweets
26
Following
5
Followers
3
Tweets last 30 days
0
Avg. likes per Tweet
33.3%
Tweets with engagement
IMIDomics Frequently Asked Questions
When was IMIDomics founded?
IMIDomics was founded in 2015.
How many employees does IMIDomics have?
IMIDomics has 3 employees.
Who are IMIDomics competitors?
Competitors of IMIDomics include ImevaX, Appello Pharmaceuticals and BioArctic.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies